Join to View Full Profile
505 E 70th StNew York, NY 10021
Phone+1 612-867-6002
Dr. Knorr is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2014 - 2017
University of Minnesota Medical SchoolClass of 2014
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology
Certifications & Licensure
NY State Medical License 2019 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Fc-optimized anti-CTLA-4 antibodies increase tumor-associated high endothelial venules and sensitize refractory tumors to PD-1 blockade.Lucas Blanchard, Estefania Vina, Jerko Ljubetic, Cécile Meneur, Dorian Tarroux
Cell Reports. Medicine. 2025-06-02 - 3 citationsIntratumoral Fc-optimized agonistic CD40 antibody induces tumor rejection and systemic antitumor immunity in patients with metastatic cancer.Juan C Osorio, David A Knorr, Polina Weitzenfeld, Ning Yao, Maria Baez
Research Square. 2024-06-03 - 9 citationsFcγRIIB Is an Immune Checkpoint Limiting the Activity of Treg-Targeting Antibodies in the Tumor Microenvironment.David A Knorr, Lucas Blanchard, Rom S Leidner, Shawn M Jensen, Ryan Meng
Cancer Immunology Research. 2024-03-04
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
